Neutrophilic Inflammation in Lung Cancer and Its Markers
Author Information
Author(s): Carpagnano Giovanna E, Palladino Grazia P, Lacedonia Donato, Koutelou Anna, Orlando Silvio, Foschino-Barbaro Maria P
Primary Institution: Department of Medical and Occupational Sciences, Institute of Respiratory Disease, University of Foggia
Hypothesis
What is the role of LTB-4 and IL-8 in the breath of NSCLC patients in relation to cancer development and progression?
Conclusion
High levels of LTB-4 and IL-8 in the breath of NSCLC patients indicate neutrophilic inflammation and may serve as non-invasive markers for lung cancer.
Supporting Evidence
- LTB-4 and IL-8 levels were significantly higher in NSCLC patients compared to controls.
- Higher concentrations of LTB-4 and IL-8 were found as cancer stages progressed.
- A positive correlation was observed between exhaled IL-8 and LTB-4 and the percentage of neutrophils in induced sputum.
Takeaway
This study found that patients with lung cancer have higher levels of certain proteins in their breath, which could help doctors diagnose and monitor the disease without needing invasive tests.
Methodology
The study measured LTB-4 and IL-8 in breath condensate and blood from NSCLC patients and controls using enzyme immunoassays.
Potential Biases
Potential bias due to the non-random selection of participants and the reliance on self-reported smoking status.
Limitations
The study did not explore the differences in LTB-4 and IL-8 levels among different histological types of NSCLC.
Participant Demographics
50 NSCLC patients (36 males, 14 females) and 35 healthy controls (18 males, 17 females), average age 65 years.
Statistical Information
P-Value
<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website